NSETrading Window1d ago · 21 Sept 2026, 12:02 pm
Trading Window
Krebs Biochemicals and Industries Limited · KREBSBIO
✦ AI SummaryResults
Krebs Biochemicals and Industries Limited has informed the Exchange regarding the closure of the trading window for insiders due to the upcoming announcement of unaudited financial results for the 2nd quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
KREBSBIO_21092026120211_Sept_2026__Closure_of_Trading_Window_signed.pdf
View document text
Krebs Biochemicals & Industries Limited
CIN: L24110AP1991PLC103912
September 21, 2026
To, To,
BSE Limited National Stock Exchange of India Ltd
P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex,
Fort, Mumbai- 400001. Bandra(E), Mumbai- 400051.
BSE Scrip Code: 524518 NSE Scrip Code: KREBSBIO
Sub: Closure of Trading Window
This is to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015,
trading window for dealings in securities of the Company shall remain closed with effect
from close of business hours on September 30, 2026 un-till 48 hours after the declaration of
Unaudited Financial Results for 2nd quarter and half year ended September 30, 2026 for
promoters, directors, designated persons, their immediate relatives and all connected
persons covered under the said code.
The date of the Board meeting for consideration of the said Unaudited Financial Results
would be intimated to the stock exchanges in due course of time.
This is for the information please.
Thanking you,
Yours Faithfully
For Krebs Biochemicals & Industries Limited
Rakesh R Kalbate
Company Secretary & Compliance Officer
ACS 66666
Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031
Tel : 040-66808040, Website: www.krebsbiochem.com, Email: com_sec@krebsbiochem.com